Luminex Corporation Announces the Release of xPONENT® 3.1 Software
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Luminex Corporation has announced the commercial release of xPONENT® 3.1 data acquisition software. Launched for use on Luminex 100 and Luminex 200 systems, xPONENT 3.1 includes more than 65 new features designed to benefit scientists and laboratory professionals across research and clinical diagnostic markets in simplifying laboratory workflow and increasing productivity.
Luminex simultaneously announced that it has added xPONENT 3.1 to its FDA-cleared Luminex 100 and 200 systems for use in clinical diagnostic applications.
xPONENT 3.1 was developed with direct feedback from users across a range of research and clinical diagnostic disciplines. The software is being released together with repackaged system reagents and a new Automated Maintenance Plate (AMP). These components combine to enable the automation of daily system maintenance operations and to increase walk-away time.
New features and enhancements of the xPONENT 3.1 software product line include a navigation structure, touch-screen capability, intra-well normalization function, advanced data-analysis tools and an enhanced database and underlying data management architecture.
For laboratories working under the FDA’s 21 CFR part 11 regulations, xPONENT software offers multilevel user management, full audit trail electronic records and electronic signatures. The software can be included in integrated systems interfaced with Laboratory Information Systems (LIS/LIMS) and front-end automation platforms. It has been designed to support both carboxylated and magnetic bead applications.
xPONENT 3.1 will be sold on new Luminex systems and will be available as an upgrade to the more than 5,800 existing Luminex 100 and 200 systems in the marketplace worldwide.
Luminex simultaneously announced that it has added xPONENT 3.1 to its FDA-cleared Luminex 100 and 200 systems for use in clinical diagnostic applications.
xPONENT 3.1 was developed with direct feedback from users across a range of research and clinical diagnostic disciplines. The software is being released together with repackaged system reagents and a new Automated Maintenance Plate (AMP). These components combine to enable the automation of daily system maintenance operations and to increase walk-away time.
New features and enhancements of the xPONENT 3.1 software product line include a navigation structure, touch-screen capability, intra-well normalization function, advanced data-analysis tools and an enhanced database and underlying data management architecture.
For laboratories working under the FDA’s 21 CFR part 11 regulations, xPONENT software offers multilevel user management, full audit trail electronic records and electronic signatures. The software can be included in integrated systems interfaced with Laboratory Information Systems (LIS/LIMS) and front-end automation platforms. It has been designed to support both carboxylated and magnetic bead applications.
xPONENT 3.1 will be sold on new Luminex systems and will be available as an upgrade to the more than 5,800 existing Luminex 100 and 200 systems in the marketplace worldwide.
